Leaving Sri Lanka

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

IMF has approved a $3bn bailout package for the bankrupted Sri Lanka. The nation's foreign minister pledged to reconstruct its state-own enterprises and their national airline but it seems like there is still a long road ahead for the island in South Asia, after getting multiple ...  Show more

Sri Lanka's economic crisis seems to be going from bad to worse. The government has now restricted the sale of fuel days after the Prime Minister said the economy had completely collapsed. So what's caused the crisis? And what are the consequences? Join host Hashem Ahelbarra  Gue ...  Show more

Sri Lanka is facing dire fuel and food shortages amid ongoing economic and political crises. In this week’s episode, the FT’s Antoni Slodkowski shares what he’s seen after a week of reporting in Sri Lanka. And then, emerging markets correspondent Jonathan Wheatley explains how ...

Sri Lanka’s president just resigned after months of protest and a deepening economic crisis. Despite Rajapaksa’s departure and the celebratory scenes of demonstrators partying at the president’s home, the people of Sri Lanka have a massive debt hole to climb out of and people hav ...  Show more